The global pharmacovigilance outsourcing market was valued at USD 8.3 billion in 2025 and is projected to reach USD 16.3 billion by 2036. The industry is expected to witness robust growth, expanding at a CAGR of 6.3% during the forecast period from 2026 to 2036, driven by increasing drug safety regulations, rising clinical trial activities, and the growing need for cost-effective monitoring solutions.

👉 Get sample market research report copy today@ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=67868

Market Overview

Pharmacovigilance outsourcing refers to the practice of pharmaceutical, biotechnology, and medical device companies delegating drug safety and adverse event monitoring activities to specialized third-party service providers. It includes services such as case processing, signal detection, risk management, medical review, aggregate reporting, regulatory compliance, and safety database management to ensure continuous monitoring of product safety throughout its lifecycle

Analysts’ Viewpoint on the PV Outsourcing Market

The global pharmacovigilance outsourcing market is expanding rapidly as biopharmaceutical companies increasingly delegate drug safety monitoring and compliance activities to experienced external vendors and specialized service providers. The market growth driver results from increasing clinical trial activities which create higher requirements for adverse event reporting and safety surveillance that pharmaceutical companies must follow.

Pharmaceutical companies need to outsource their pharmacovigilance services as it helps them decrease their internal costs while vendors handle their complex case management and regulatory submission needs. The market faces challenges as different regions have different regulatory systems which create difficulties for standardizing processes and generate compliance problems for both sponsors and providers.

Analysis of Key Players

The market is highly competitive, featuring global CRO giants, IT consulting firms, and niche pharmacovigilance specialists.

Leading companies operating in the global market include:

• Accenture
• ArisGlobal
• Biomapas
• Capgemini
• Cognizant
• ICON plc
• IQVIA Inc.
• Parexel International
• PrimeVigilance Ltd.
• ProPharma
• TATA Consultancy Services Limited
• United BioSource LLC
• Wipro
• Other Prominent Players

Recent Developments in PV Outsourcing

• In February 2026, ArisGlobal, recently announced the launch of NavaX Translation, a new solution delivered through a strategic partnership with TransPerfect Life Sciences to eliminate manual translation in global pharmacovigilance. NavaX Translation brings certified, pharma-grade translation and multilingual content directly into LifeSphere Safety workflows, enabling faster, more accurate, and fully compliant multilingual case processing at a global scale
• In September 2025, ACL Digital announced the acquisition of Symbiance, a data-driven, technology-enabled Contract Research Organization (CRO) with over three decades of proven expertise in clinical data services and operations, medical monitoring, project management, medical writing, and pharmacovigilance segments. The acquisition of Symbiance by ACL Digital solidifies its position as an end-to-end provider of clinical research and data CRO solutions on a global scale.

👉 Discuss Implications for Your Pipeline Request Sample Research Report PDF@ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=67868

Key Market Trends & Strategies

🤖 AI & Automation Integration

The “manual era” is ending. In 2026, providers are using AI to automate Individual Case Safety Reports (ICSRs), literature monitoring, and even initial signal assessment, allowing human medical reviewers to focus on high-level risk-benefit analysis.

📈 Market Challenges

• Data Privacy & Security: Cross-border transfer of sensitive patient data remains a high-profile risk, particularly between EU and non-EU corridors.
• Skilled Professional Shortage: There is a persistent global gap of roughly 5,000 PV specialists, leading to wage competition and high turnover in major hubs like India and Poland.

🌟 Growth Opportunities

• Medical Device Vigilance: The implementation of the EU Medical Device Regulation (MDR) has created a massive secondary market for device-specific safety monitoring.
• Emerging APAC Hubs: China and Japan are seeing a surge in local PV requirements, making them the fastest-growing regional targets for global vendors.

Market Segmentation

By Service Type

• Individual Case Safety Reports (ICSRs)
• Literature Monitoring
• Aggregate Reporting (PSUR/PBRER, DSUR, etc.)
• Signal Detection & Risk Management
• Risk Management Plans (RMP)
• Pharmacovigilance Audits & Training
• Safety Database Hosting & Maintenance
• Medical Device Vigilance
• Regulatory & Compliance Support
• Others (Quality management, SOP development, etc.)

By Therapeutic Area

• Oncology
• Neurology
• Cardiology
• Immunology
• Respiratory
• Infectious Diseases
• Gastroenterology
• Orthopedics & Musculoskeletal Disorders
• Others (Dermatology, Endocrinology, etc.)

By Service Provider

• Contract Research Organizations (CROs)
• Business Process Outsourcing (BPO) Providers
• Specialized Pharmacovigilance Service Providers
• Others (Software Vendors, etc.)

By End-user

• Pharmaceutical Companies
• Biotechnology Companies
• Medical Device Manufacturers
• Research Organizations
• Others (Government Agencies, etc.)

Regional Outlook

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Conclusion

In 2026, Pharmacovigilance Outsourcing has moved from a transactional “data entry” service to a strategic “Predictive Safety” partnership. As the volume of real-world evidence (RWE) and social media patient data floods the industry, the winners will be those who can integrate AI to filter out the noise and identify genuine safety signals with unprecedented speed. For manufacturers, the goal is simple: maximize patient safety while minimizing the massive operational burden of global compliance.

👉 To buy this comprehensive market research report, click here to inquire@ https://www.transparencymarketresearch.com/checkout.php?rep_id=67868&ltype=S

FAQs

• How big was the global pharmacovigilance outsourcing market in 2025?

The global pharmacovigilance outsourcing market was valued at USD 8.3 Billion in 2025

• What is the projected size of the pharmacovigilance outsourcing market by 2036?

The global pharmacovigilance outsourcing market is projected to cross USD 16.3 Billion by the end of 2036

• What are the factors driving the pharmacovigilance outsourcing industry?

Rising volume of clinical trials & new drug approvals and growing presence of CROs & BPOs globally

• What is the pharmacovigilance outsourcing market expected to grow during the forecast period?

The global pharmacovigilance outsourcing market is anticipated to grow at a CAGR 6.3% from 2026 to 2036

• Which region is expected to dominate the pharmacovigilance outsourcing market during the forecast period?

North America is expected to account for the largest share from 2026 to 2036

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:

Abhishek Budholiya
Transparency Market Research Inc.
State Tower, 90 State Street, Suite 700,
Albany NY – 12207, United States
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Sales Inquiries: sales@transparencymarketresearch.com
Media Inquiries: media@transparencymarketresearch.com